Literature DB >> 23829560

Structural evidence: a single charged residue affects substrate binding in cytochrome P450 BM-3.

Jaclyn Catalano1, Kianoush Sadre-Bazzaz, Gabriele A Amodeo, Liang Tong, Ann McDermott.   

Abstract

Cytochrome P450 BM-3 is a bacterial enzyme with sequence similarity to mammalian P450s that catalyzes the hydroxylation of fatty acids with high efficiency. Enzyme-substrate binding and dynamics has been an important topic of study for cytochromes P450 because most of the crystal structures of substrate-bound structures show the complex in an inactive state. We have determined a new crystal structure for cytochrome P450 BM-3 in complex with N-palmitoylglycine (NPG), which unexpectedly showed a direct bidentate ion pair between NPG and arginine 47 (R47). We further explored the role of R47, the only charged residue in the binding pocket in cytochrome P450 BM-3, through mutagenesis and crystallographic studies. The mutations of R47 to glutamine (R47Q), glutamic acid (R47E), and lysine (R47K) were designed to investigate the role of its charge in binding and catalysis. The oppositely charged R47E mutation had the greatest effect on activity and binding. The crystal structure of R47E BMP shows that the glutamic acid side chain is blocking the entrance to the binding pocket, accounting for NPG's low binding affinity and charge repulsion. For R47Q and R47K BM-3, the mutations caused only a slight change in kcat and a large change in Km and Kd, which suggests that R47 mostly is involved in binding and that our crystal structure, 4KPA , represents an initial binding step in the P450 cycle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23829560      PMCID: PMC5945292          DOI: 10.1021/bi4000645

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  72 in total

1.  Interactions of substrates at the surface of P450s can greatly enhance substrate potency.

Authors:  Amita Hegde; Donovan C Haines; Muralidhar Bondlela; Baozhi Chen; Nathaniel Schaffer; Diana R Tomchick; Mischa Machius; Hien Nguyen; Puneet K Chowdhary; Larissa Stewart; Claudia Lopez; Julian A Peterson
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

2.  The role of Thr268 and Phe393 in cytochrome P450 BM3.

Authors:  Jonathan P Clark; Caroline S Miles; Christopher G Mowat; Malcolm D Walkinshaw; Graeme A Reid; Simon N Daff; Stephen K Chapman
Journal:  J Inorg Biochem       Date:  2006-01-05       Impact factor: 4.155

3.  Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant.

Authors:  Q S Li; U Schwaneberg; M Fischer; J Schmitt; J Pleiss; S Lutz-Wahl; R D Schmid
Journal:  Biochim Biophys Acta       Date:  2001-02-09

4.  NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.

Authors:  S Modi; W U Primrose; J M Boyle; C F Gibson; L Y Lian; G C Roberts
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

5.  A single mutation in P450BM-3 enhances acyl homoserine lactone: acyl homoserine substrate binding selectivity nearly 250-fold.

Authors:  Puneet K Chowdhary; Larissa Stewart; Claudia Lopez; Donovan C Haines
Journal:  J Biotechnol       Date:  2008-05-20       Impact factor: 3.307

6.  The role of Thr268 in oxygen activation of cytochrome P450BM-3.

Authors:  H Yeom; S G Sligar; H Li; T L Poulos; A J Fulco
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

7.  Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.

Authors:  Tuck Seng Wong; Frances H Arnold; Ulrich Schwaneberg
Journal:  Biotechnol Bioeng       Date:  2004-02-05       Impact factor: 4.530

8.  Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450BM3 demethylases.

Authors:  Jared C Lewis; Sabine Bastian; Clay S Bennett; Yu Fu; Yuuichi Mitsuda; Mike M Chen; William A Greenberg; Chi-Huey Wong; Frances H Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

Review 9.  Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.

Authors:  A J Warman; O Roitel; R Neeli; H M Girvan; H E Seward; S A Murray; K J McLean; M G Joyce; H Toogood; R A Holt; D Leys; N S Scrutton; A W Munro
Journal:  Biochem Soc Trans       Date:  2005-08       Impact factor: 5.407

10.  Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.

Authors:  Hazel M Girvan; Harriet E Seward; Helen S Toogood; Myles R Cheesman; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2006-10-31       Impact factor: 5.157

View more
  2 in total

1.  The use of reaction timecourses to determine the level of minor contaminants in enzyme preparations.

Authors:  Lawrence M Goldman; Tina L Amyes
Journal:  Anal Biochem       Date:  2014-01-03       Impact factor: 3.365

2.  Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.

Authors:  Jessica Spradlin; Diana Lee; Sruthi Mahadevan; Mavish Mahomed; Lawrence Tang; Quan Lam; Alexander Colbert; Oliver S Shafaat; David Goodin; Marco Kloos; Mallory Kato; Lionel E Cheruzel
Journal:  Biochim Biophys Acta       Date:  2016-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.